In gains, 108 cancer genes were altered in at least 25% of the samples, including the oncogenes CSF1, EVI5, ITGA3, JAK2, KIT, NCOA3, NTRK1, PPM1D, and TYRP1. This evidence concerns the gene ITGA3 and cancer.